ATE354583T1 - Verfahren zur herstellung c-7 substituierter 5- androstene - Google Patents
Verfahren zur herstellung c-7 substituierter 5- androsteneInfo
- Publication number
- ATE354583T1 ATE354583T1 AT03716433T AT03716433T ATE354583T1 AT E354583 T1 ATE354583 T1 AT E354583T1 AT 03716433 T AT03716433 T AT 03716433T AT 03716433 T AT03716433 T AT 03716433T AT E354583 T1 ATE354583 T1 AT E354583T1
- Authority
- AT
- Austria
- Prior art keywords
- androstenes
- substituted
- producing
- novel
- processes
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- -1 steroid compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42448802P | 2002-11-07 | 2002-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE354583T1 true ATE354583T1 (de) | 2007-03-15 |
Family
ID=32312815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03716433T ATE354583T1 (de) | 2002-11-07 | 2003-03-21 | Verfahren zur herstellung c-7 substituierter 5- androstene |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20040097475A1 (de) |
| EP (1) | EP1562974B1 (de) |
| JP (1) | JP2006508962A (de) |
| KR (1) | KR100667123B1 (de) |
| CN (1) | CN1694896A (de) |
| AT (1) | ATE354583T1 (de) |
| AU (1) | AU2003220139A1 (de) |
| BR (1) | BR0316052A (de) |
| CA (1) | CA2500580A1 (de) |
| DE (1) | DE60312029T2 (de) |
| ES (1) | ES2280739T3 (de) |
| HK (1) | HK1080088A1 (de) |
| MX (1) | MXPA05004024A (de) |
| PL (1) | PL376896A1 (de) |
| RS (1) | RS20050339A (de) |
| RU (1) | RU2289586C2 (de) |
| TW (1) | TWI280133B (de) |
| WO (1) | WO2004043986A1 (de) |
| ZA (1) | ZA200502698B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235655B2 (en) * | 2002-03-22 | 2007-06-26 | Pharmacia & Upjohn Company | Processes to prepare eplerenone |
| CN1321128C (zh) * | 2005-07-15 | 2007-06-13 | 浙江医药股份有限公司新昌制药厂 | 孕甾－4－烯－7，21－二甲酸，9，11－环氧－17－羟基－3－氧代，γ－内酯，甲酯，(7α,11α,17α)－的制备方法 |
| CN101472579B (zh) * | 2006-04-22 | 2013-07-03 | 霍利斯-伊登医药公司 | 药物和用途 |
| EP2486924B1 (de) * | 2006-04-22 | 2018-12-26 | Neurmedix, Inc. | Wirkstoffe und deren Anwendungen |
| US8486926B2 (en) * | 2006-11-17 | 2013-07-16 | Harbor Therapeutics, Inc. | Steroid tetrol solid state forms |
| US8354396B2 (en) * | 2006-11-17 | 2013-01-15 | Harbor Therapeutics, Inc. | Drug identification and treatment method |
| US8217025B2 (en) * | 2006-11-17 | 2012-07-10 | Harbor Therapeutics, Inc. | Drug screening and treatment methods |
| US20080153792A1 (en) * | 2006-11-17 | 2008-06-26 | Frincke James M | Drug Identification and Treatment Method |
| US20080221074A1 (en) * | 2006-11-17 | 2008-09-11 | Jaime Flores-Riveros | Drug Screen and Treatment Method |
| CN102046647A (zh) * | 2008-06-06 | 2011-05-04 | 哈博生物科学公司 | 制备17-炔基-7-羟基甾族化合物和相关化合物的方法 |
| US20100222315A1 (en) * | 2008-09-24 | 2010-09-02 | Harbor BioSciencs, Inc. | Patient populations and treatment methods |
| US20100227841A1 (en) * | 2008-09-24 | 2010-09-09 | Harbor BioSciencs, Inc. | Patient populations and treatment methods |
| WO2010036822A1 (en) * | 2008-09-24 | 2010-04-01 | Hollis-Eden Pharmaceuticals, Inc. | Patient populations and treatment methods |
| CN103087139B (zh) * | 2011-11-08 | 2016-08-03 | 中国科学院上海药物研究所 | 一种坎利酮衍生物类甾体化合物、其制备方法及其在制备依普利酮中的用途 |
| CN105753930A (zh) * | 2016-03-30 | 2016-07-13 | 北京万全德众医药生物技术有限公司 | 依普利酮的一种合成方法 |
| CN110698529A (zh) * | 2019-11-19 | 2020-01-17 | 湖南新合新生物医药有限公司 | 一种依普利酮中间体△9,11烯酯的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069219A (en) * | 1976-12-27 | 1978-01-17 | G. D. Searle & Co. | 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters |
| FI77669C (fi) * | 1983-04-13 | 1989-04-10 | Ciba Geigy Ag | 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat. |
| US5227375A (en) * | 1990-02-08 | 1993-07-13 | Endorecherche, Inc. | Aromatase inhibitors |
| US5237064A (en) * | 1992-05-20 | 1993-08-17 | Merck & Co., Inc. | Process for producing 7β-substituted-aza-5αandrostan-3-ones |
| ATE365171T1 (de) * | 1995-12-11 | 2007-07-15 | Searle Llc | Verfahren zur herstellung einer epoxyverbindung |
| ES2293944T3 (es) * | 1996-12-11 | 2008-04-01 | G.D. Searle Llc. | Procedimiento de epoxidacion. |
| US6887991B1 (en) * | 1996-12-11 | 2005-05-03 | G. D. Searle & Company | Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| US6716829B2 (en) * | 2000-07-27 | 2004-04-06 | Pharmacia Corporation | Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
-
2003
- 2003-03-21 DE DE60312029T patent/DE60312029T2/de not_active Expired - Fee Related
- 2003-03-21 EP EP03716433A patent/EP1562974B1/de not_active Expired - Lifetime
- 2003-03-21 BR BR0316052-1A patent/BR0316052A/pt not_active IP Right Cessation
- 2003-03-21 TW TW092106330A patent/TWI280133B/zh not_active IP Right Cessation
- 2003-03-21 AU AU2003220139A patent/AU2003220139A1/en not_active Abandoned
- 2003-03-21 RU RU2005117372/04A patent/RU2289586C2/ru not_active IP Right Cessation
- 2003-03-21 US US10/392,945 patent/US20040097475A1/en not_active Abandoned
- 2003-03-21 MX MXPA05004024A patent/MXPA05004024A/es unknown
- 2003-03-21 CN CNA038248697A patent/CN1694896A/zh active Pending
- 2003-03-21 KR KR1020057008024A patent/KR100667123B1/ko not_active IP Right Cessation
- 2003-03-21 JP JP2004551389A patent/JP2006508962A/ja not_active Withdrawn
- 2003-03-21 RS YUP-2005/0339A patent/RS20050339A/sr unknown
- 2003-03-21 ES ES03716433T patent/ES2280739T3/es not_active Expired - Lifetime
- 2003-03-21 PL PL376896A patent/PL376896A1/pl not_active Application Discontinuation
- 2003-03-21 WO PCT/US2003/007284 patent/WO2004043986A1/en active IP Right Grant
- 2003-03-21 AT AT03716433T patent/ATE354583T1/de not_active IP Right Cessation
- 2003-03-21 CA CA002500580A patent/CA2500580A1/en not_active Abandoned
-
2005
- 2005-04-04 ZA ZA200502698A patent/ZA200502698B/en unknown
- 2005-12-31 HK HK05112224.8A patent/HK1080088A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05004024A (es) | 2005-06-08 |
| HK1080088A1 (zh) | 2006-04-21 |
| RU2005117372A (ru) | 2006-01-20 |
| US20040097475A1 (en) | 2004-05-20 |
| AU2003220139A1 (en) | 2004-06-03 |
| EP1562974A1 (de) | 2005-08-17 |
| RS20050339A (sr) | 2007-08-03 |
| KR100667123B1 (ko) | 2007-01-12 |
| RU2289586C2 (ru) | 2006-12-20 |
| PL376896A1 (pl) | 2006-01-09 |
| TWI280133B (en) | 2007-05-01 |
| CA2500580A1 (en) | 2004-05-27 |
| KR20050084953A (ko) | 2005-08-29 |
| DE60312029D1 (de) | 2007-04-05 |
| TW200407151A (en) | 2004-05-16 |
| ZA200502698B (en) | 2006-07-26 |
| DE60312029T2 (de) | 2007-06-21 |
| BR0316052A (pt) | 2005-09-20 |
| ES2280739T3 (es) | 2007-09-16 |
| CN1694896A (zh) | 2005-11-09 |
| WO2004043986A1 (en) | 2004-05-27 |
| JP2006508962A (ja) | 2006-03-16 |
| EP1562974B1 (de) | 2007-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE425136T1 (de) | Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen | |
| HK1080088A1 (zh) | 製備c-7取代的5-雄甾烯的方法 | |
| ATE435209T1 (de) | Verfahren zur herstellung von montelukast-natrium | |
| ATE501264T1 (de) | Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate | |
| ATE478084T1 (de) | Verfahren zur herstellung von 4'- azidocytidinderivaten | |
| EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| MX2007007446A (es) | Procesos para la produccion de 4-aminoquinazolinas. | |
| ATE447567T1 (de) | Verfahren zur herstellung von tryptase- inhibitoren | |
| ATE489352T1 (de) | Verfahren zur herstellung von brenztraubensäure | |
| EA200702428A1 (ru) | Способы получения 4-бифенилилазетидин-2-онов | |
| ATE423096T1 (de) | Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| DE60223279D1 (de) | Verfahren für die herstellung substituierter bicyclischer derivate zur behandlung von anomalem zellwachstum | |
| ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
| ATE423775T1 (de) | Verfahren zur herstellung von lactonen | |
| DE602004008486D1 (de) | Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| DE602004014822D1 (de) | Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol | |
| ATE502045T1 (de) | Verfahren zur herstellung von perindoprilerbumin | |
| DE602004031727D1 (de) | Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden | |
| ATE380183T1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
| ATE515502T1 (de) | Verfahren zur herstellung von tetranorlabdanderivaten | |
| DE602004030091D1 (de) | Verfahren zur reduktiven deshalogenierung | |
| ATE387423T1 (de) | Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten | |
| DE50203388D1 (de) | Verbessertes verfahren zur herstellung von bisphosphiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |